Cargando…
Elevated serum IL-10 is associated with severity of neonatal encephalopathy and adverse early childhood outcomes
BACKGROUND: Neonatal encephalopathy (NE) contributes substantially to child mortality and disability globally. We compared cytokine profiles in term Ugandan neonates with and without NE, with and without perinatal infection or inflammation and identified biomarkers predicting neonatal and early chil...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411052/ https://www.ncbi.nlm.nih.gov/pubmed/33674741 http://dx.doi.org/10.1038/s41390-021-01438-1 |
_version_ | 1784775234270789632 |
---|---|
author | Pang, Raymand Mujuni, Brian M. Martinello, Kathryn A. Webb, Emily L. Nalwoga, Angela Ssekyewa, Julius Musoke, Margaret Kurinczuk, Jennifer J. Sewegaba, Margaret Cowan, Frances M. Cose, Stephen Nakakeeto, Margaret Elliott, Alison M. Sebire, Neil J. Klein, Nigel Robertson, Nicola J. Tann, Cally J. |
author_facet | Pang, Raymand Mujuni, Brian M. Martinello, Kathryn A. Webb, Emily L. Nalwoga, Angela Ssekyewa, Julius Musoke, Margaret Kurinczuk, Jennifer J. Sewegaba, Margaret Cowan, Frances M. Cose, Stephen Nakakeeto, Margaret Elliott, Alison M. Sebire, Neil J. Klein, Nigel Robertson, Nicola J. Tann, Cally J. |
author_sort | Pang, Raymand |
collection | PubMed |
description | BACKGROUND: Neonatal encephalopathy (NE) contributes substantially to child mortality and disability globally. We compared cytokine profiles in term Ugandan neonates with and without NE, with and without perinatal infection or inflammation and identified biomarkers predicting neonatal and early childhood outcomes. METHODS: In this exploratory biomarker study, serum IL-1α, IL-6, IL-8, IL-10, TNFα, and VEGF (<12 h) were compared between NE and non-NE infants with and without perinatal infection/inflammation. Neonatal (severity of NE, mortality) and early childhood (death or neurodevelopmental impairment to 2.5 years) outcomes were assessed. Predictors of outcomes were explored with multivariable linear and logistic regression and receiver-operating characteristic analyses. RESULTS: Cytokine assays on 159 NE and 157 non-NE infants were performed; data on early childhood outcomes were available for 150 and 129, respectively. NE infants had higher IL-10 (p < 0.001), higher IL-6 (p < 0.017), and lower VEGF (p < 0.001) levels. Moderate and severe NE was associated with higher IL-10 levels compared to non-NE infants (p < 0.001). Elevated IL-1α was associated with perinatal infection/inflammation (p = 0.013). Among NE infants, IL-10 predicted neonatal mortality (p = 0.01) and adverse early childhood outcome (adjusted OR 2.28, 95% CI 1.35–3.86, p = 0.002). CONCLUSIONS: Our findings support a potential role for IL-10 as a biomarker for adverse outcomes after neonatal encephalopathy. IMPACT: Neonatal encephalopathy is a common cause of child death and disability globally. Inflammatory cytokines are potential biomarkers of encephalopathy severity and outcome. In this Ugandan health facility-based cohort, neonatal encephalopathy was associated with elevated serum IL-10 and IL-6, and reduced VEGF at birth. Elevated serum IL-10 within 12 h after birth predicted severity of neonatal encephalopathy, neonatal mortality, and adverse early childhood developmental outcomes, independent of perinatal infection or inflammation, and provides evidence to the contribution of the inflammatory processes. Our findings support a role for IL-10 as a biomarker for adverse outcomes after neonatal encephalopathy in a sub-Saharan African cohort. |
format | Online Article Text |
id | pubmed-9411052 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-94110522022-08-27 Elevated serum IL-10 is associated with severity of neonatal encephalopathy and adverse early childhood outcomes Pang, Raymand Mujuni, Brian M. Martinello, Kathryn A. Webb, Emily L. Nalwoga, Angela Ssekyewa, Julius Musoke, Margaret Kurinczuk, Jennifer J. Sewegaba, Margaret Cowan, Frances M. Cose, Stephen Nakakeeto, Margaret Elliott, Alison M. Sebire, Neil J. Klein, Nigel Robertson, Nicola J. Tann, Cally J. Pediatr Res Clinical Research Article BACKGROUND: Neonatal encephalopathy (NE) contributes substantially to child mortality and disability globally. We compared cytokine profiles in term Ugandan neonates with and without NE, with and without perinatal infection or inflammation and identified biomarkers predicting neonatal and early childhood outcomes. METHODS: In this exploratory biomarker study, serum IL-1α, IL-6, IL-8, IL-10, TNFα, and VEGF (<12 h) were compared between NE and non-NE infants with and without perinatal infection/inflammation. Neonatal (severity of NE, mortality) and early childhood (death or neurodevelopmental impairment to 2.5 years) outcomes were assessed. Predictors of outcomes were explored with multivariable linear and logistic regression and receiver-operating characteristic analyses. RESULTS: Cytokine assays on 159 NE and 157 non-NE infants were performed; data on early childhood outcomes were available for 150 and 129, respectively. NE infants had higher IL-10 (p < 0.001), higher IL-6 (p < 0.017), and lower VEGF (p < 0.001) levels. Moderate and severe NE was associated with higher IL-10 levels compared to non-NE infants (p < 0.001). Elevated IL-1α was associated with perinatal infection/inflammation (p = 0.013). Among NE infants, IL-10 predicted neonatal mortality (p = 0.01) and adverse early childhood outcome (adjusted OR 2.28, 95% CI 1.35–3.86, p = 0.002). CONCLUSIONS: Our findings support a potential role for IL-10 as a biomarker for adverse outcomes after neonatal encephalopathy. IMPACT: Neonatal encephalopathy is a common cause of child death and disability globally. Inflammatory cytokines are potential biomarkers of encephalopathy severity and outcome. In this Ugandan health facility-based cohort, neonatal encephalopathy was associated with elevated serum IL-10 and IL-6, and reduced VEGF at birth. Elevated serum IL-10 within 12 h after birth predicted severity of neonatal encephalopathy, neonatal mortality, and adverse early childhood developmental outcomes, independent of perinatal infection or inflammation, and provides evidence to the contribution of the inflammatory processes. Our findings support a role for IL-10 as a biomarker for adverse outcomes after neonatal encephalopathy in a sub-Saharan African cohort. Nature Publishing Group US 2021-03-05 2022 /pmc/articles/PMC9411052/ /pubmed/33674741 http://dx.doi.org/10.1038/s41390-021-01438-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Clinical Research Article Pang, Raymand Mujuni, Brian M. Martinello, Kathryn A. Webb, Emily L. Nalwoga, Angela Ssekyewa, Julius Musoke, Margaret Kurinczuk, Jennifer J. Sewegaba, Margaret Cowan, Frances M. Cose, Stephen Nakakeeto, Margaret Elliott, Alison M. Sebire, Neil J. Klein, Nigel Robertson, Nicola J. Tann, Cally J. Elevated serum IL-10 is associated with severity of neonatal encephalopathy and adverse early childhood outcomes |
title | Elevated serum IL-10 is associated with severity of neonatal encephalopathy and adverse early childhood outcomes |
title_full | Elevated serum IL-10 is associated with severity of neonatal encephalopathy and adverse early childhood outcomes |
title_fullStr | Elevated serum IL-10 is associated with severity of neonatal encephalopathy and adverse early childhood outcomes |
title_full_unstemmed | Elevated serum IL-10 is associated with severity of neonatal encephalopathy and adverse early childhood outcomes |
title_short | Elevated serum IL-10 is associated with severity of neonatal encephalopathy and adverse early childhood outcomes |
title_sort | elevated serum il-10 is associated with severity of neonatal encephalopathy and adverse early childhood outcomes |
topic | Clinical Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411052/ https://www.ncbi.nlm.nih.gov/pubmed/33674741 http://dx.doi.org/10.1038/s41390-021-01438-1 |
work_keys_str_mv | AT pangraymand elevatedserumil10isassociatedwithseverityofneonatalencephalopathyandadverseearlychildhoodoutcomes AT mujunibrianm elevatedserumil10isassociatedwithseverityofneonatalencephalopathyandadverseearlychildhoodoutcomes AT martinellokathryna elevatedserumil10isassociatedwithseverityofneonatalencephalopathyandadverseearlychildhoodoutcomes AT webbemilyl elevatedserumil10isassociatedwithseverityofneonatalencephalopathyandadverseearlychildhoodoutcomes AT nalwogaangela elevatedserumil10isassociatedwithseverityofneonatalencephalopathyandadverseearlychildhoodoutcomes AT ssekyewajulius elevatedserumil10isassociatedwithseverityofneonatalencephalopathyandadverseearlychildhoodoutcomes AT musokemargaret elevatedserumil10isassociatedwithseverityofneonatalencephalopathyandadverseearlychildhoodoutcomes AT kurinczukjenniferj elevatedserumil10isassociatedwithseverityofneonatalencephalopathyandadverseearlychildhoodoutcomes AT sewegabamargaret elevatedserumil10isassociatedwithseverityofneonatalencephalopathyandadverseearlychildhoodoutcomes AT cowanfrancesm elevatedserumil10isassociatedwithseverityofneonatalencephalopathyandadverseearlychildhoodoutcomes AT cosestephen elevatedserumil10isassociatedwithseverityofneonatalencephalopathyandadverseearlychildhoodoutcomes AT nakakeetomargaret elevatedserumil10isassociatedwithseverityofneonatalencephalopathyandadverseearlychildhoodoutcomes AT elliottalisonm elevatedserumil10isassociatedwithseverityofneonatalencephalopathyandadverseearlychildhoodoutcomes AT sebireneilj elevatedserumil10isassociatedwithseverityofneonatalencephalopathyandadverseearlychildhoodoutcomes AT kleinnigel elevatedserumil10isassociatedwithseverityofneonatalencephalopathyandadverseearlychildhoodoutcomes AT robertsonnicolaj elevatedserumil10isassociatedwithseverityofneonatalencephalopathyandadverseearlychildhoodoutcomes AT tanncallyj elevatedserumil10isassociatedwithseverityofneonatalencephalopathyandadverseearlychildhoodoutcomes |